Potential use of melatonergic drugs in analgesia: Mechanisms of action
- Autores
- Srinivasan, Venkataramanujam; Pandi Perumal, Seithikurippu R.; Spence, David Warren; Moscovitch, Adam; Trakht, Ilya; Brown, Gregory M.; Cardinali, Daniel Pedro
- Año de publicación
- 2010
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Melatonin is a remarkable molecule with diverse physiological functions. Some of its effects are mediated by receptors while other, like cytoprotection, seem to depend on direct and indirect scavenging of free radicals not involving receptors. Among melatonin's many effects, its antinociceptive actions have attracted attention. When given orally, intraperitoneally, locally, intrathecally or through intracerebroventricular routes, melatonin exerts antinociceptive and antiallodynic actions in a variety of animal models. These effects have been demonstrated in animal models of acute pain like the tail-flick test, formalin test or endotoxin-induced hyperalgesia as well as in models of neuropathic pain like nerve ligation. Glutamate, gamma-aminobutyric acid, and particularly, opioid neurotransmission have been demonstrated to be involved in melatonin's analgesia. Results using melatonin receptor antagonists support the participation of melatonin receptors in melatonin's analgesia. However, discrepancies between the affinity of the receptors and the very high doses of melatonin needed to cause effects in vivo raise doubts about the uniqueness of that physiopathological interpretation. Indeed, melatonin could play a role in pain through several alternative mechanisms including free radicals scavenging or nitric oxide synthase inhibition. The use of melatonin analogs like the MT1/MT2 agonist ramelteon, which lacks free radical scavenging activity, could be useful to unravel the mechanism of action of melatonin in analgesia. Melatonin has a promising role as an analgesic drug that could be used for alleviating pain associated with cancer, headache or surgical procedures.
Fil: Srinivasan, Venkataramanujam. Shri Sathya Sai Medical College and Research Institute; India
Fil: Pandi Perumal, Seithikurippu R.. Somnogen; Estados Unidos
Fil: Spence, David Warren. Canadian Sleep Society; Canadá
Fil: Moscovitch, Adam. Canadian Sleep Society; Canadá
Fil: Trakht, Ilya. Columbia University College of Physicians and Surgeons; Estados Unidos
Fil: Brown, Gregory M.. University of Toronto; Canadá
Fil: Cardinali, Daniel Pedro. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Facultad de Ciencias Médicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina - Materia
-
ALLODYNIA
ANALGESIA
MELATONIN
MELATONIN ANALOGS
MELATONIN RECEPTORS
NEUROPATHIC PAIN
NOCICEPTION
OPIOID RECEPTORS - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/98829
Ver los metadatos del registro completo
id |
CONICETDig_dfa038812e15a684342c3fb2ff1b0d86 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/98829 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Potential use of melatonergic drugs in analgesia: Mechanisms of actionSrinivasan, VenkataramanujamPandi Perumal, Seithikurippu R.Spence, David WarrenMoscovitch, AdamTrakht, IlyaBrown, Gregory M.Cardinali, Daniel PedroALLODYNIAANALGESIAMELATONINMELATONIN ANALOGSMELATONIN RECEPTORSNEUROPATHIC PAINNOCICEPTIONOPIOID RECEPTORShttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Melatonin is a remarkable molecule with diverse physiological functions. Some of its effects are mediated by receptors while other, like cytoprotection, seem to depend on direct and indirect scavenging of free radicals not involving receptors. Among melatonin's many effects, its antinociceptive actions have attracted attention. When given orally, intraperitoneally, locally, intrathecally or through intracerebroventricular routes, melatonin exerts antinociceptive and antiallodynic actions in a variety of animal models. These effects have been demonstrated in animal models of acute pain like the tail-flick test, formalin test or endotoxin-induced hyperalgesia as well as in models of neuropathic pain like nerve ligation. Glutamate, gamma-aminobutyric acid, and particularly, opioid neurotransmission have been demonstrated to be involved in melatonin's analgesia. Results using melatonin receptor antagonists support the participation of melatonin receptors in melatonin's analgesia. However, discrepancies between the affinity of the receptors and the very high doses of melatonin needed to cause effects in vivo raise doubts about the uniqueness of that physiopathological interpretation. Indeed, melatonin could play a role in pain through several alternative mechanisms including free radicals scavenging or nitric oxide synthase inhibition. The use of melatonin analogs like the MT1/MT2 agonist ramelteon, which lacks free radical scavenging activity, could be useful to unravel the mechanism of action of melatonin in analgesia. Melatonin has a promising role as an analgesic drug that could be used for alleviating pain associated with cancer, headache or surgical procedures.Fil: Srinivasan, Venkataramanujam. Shri Sathya Sai Medical College and Research Institute; IndiaFil: Pandi Perumal, Seithikurippu R.. Somnogen; Estados UnidosFil: Spence, David Warren. Canadian Sleep Society; CanadáFil: Moscovitch, Adam. Canadian Sleep Society; CanadáFil: Trakht, Ilya. Columbia University College of Physicians and Surgeons; Estados UnidosFil: Brown, Gregory M.. University of Toronto; CanadáFil: Cardinali, Daniel Pedro. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Facultad de Ciencias Médicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaPergamon-Elsevier Science Ltd2010-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/98829Srinivasan, Venkataramanujam; Pandi Perumal, Seithikurippu R.; Spence, David Warren; Moscovitch, Adam; Trakht, Ilya; et al.; Potential use of melatonergic drugs in analgesia: Mechanisms of action; Pergamon-Elsevier Science Ltd; Brain Research Bulletin; 81; 4-5; 3-2010; 362-3710361-9230CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0361923009003670info:eu-repo/semantics/altIdentifier/doi/10.1016/j.brainresbull.2009.12.001info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-15T14:48:34Zoai:ri.conicet.gov.ar:11336/98829instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-15 14:48:35.263CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Potential use of melatonergic drugs in analgesia: Mechanisms of action |
title |
Potential use of melatonergic drugs in analgesia: Mechanisms of action |
spellingShingle |
Potential use of melatonergic drugs in analgesia: Mechanisms of action Srinivasan, Venkataramanujam ALLODYNIA ANALGESIA MELATONIN MELATONIN ANALOGS MELATONIN RECEPTORS NEUROPATHIC PAIN NOCICEPTION OPIOID RECEPTORS |
title_short |
Potential use of melatonergic drugs in analgesia: Mechanisms of action |
title_full |
Potential use of melatonergic drugs in analgesia: Mechanisms of action |
title_fullStr |
Potential use of melatonergic drugs in analgesia: Mechanisms of action |
title_full_unstemmed |
Potential use of melatonergic drugs in analgesia: Mechanisms of action |
title_sort |
Potential use of melatonergic drugs in analgesia: Mechanisms of action |
dc.creator.none.fl_str_mv |
Srinivasan, Venkataramanujam Pandi Perumal, Seithikurippu R. Spence, David Warren Moscovitch, Adam Trakht, Ilya Brown, Gregory M. Cardinali, Daniel Pedro |
author |
Srinivasan, Venkataramanujam |
author_facet |
Srinivasan, Venkataramanujam Pandi Perumal, Seithikurippu R. Spence, David Warren Moscovitch, Adam Trakht, Ilya Brown, Gregory M. Cardinali, Daniel Pedro |
author_role |
author |
author2 |
Pandi Perumal, Seithikurippu R. Spence, David Warren Moscovitch, Adam Trakht, Ilya Brown, Gregory M. Cardinali, Daniel Pedro |
author2_role |
author author author author author author |
dc.subject.none.fl_str_mv |
ALLODYNIA ANALGESIA MELATONIN MELATONIN ANALOGS MELATONIN RECEPTORS NEUROPATHIC PAIN NOCICEPTION OPIOID RECEPTORS |
topic |
ALLODYNIA ANALGESIA MELATONIN MELATONIN ANALOGS MELATONIN RECEPTORS NEUROPATHIC PAIN NOCICEPTION OPIOID RECEPTORS |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Melatonin is a remarkable molecule with diverse physiological functions. Some of its effects are mediated by receptors while other, like cytoprotection, seem to depend on direct and indirect scavenging of free radicals not involving receptors. Among melatonin's many effects, its antinociceptive actions have attracted attention. When given orally, intraperitoneally, locally, intrathecally or through intracerebroventricular routes, melatonin exerts antinociceptive and antiallodynic actions in a variety of animal models. These effects have been demonstrated in animal models of acute pain like the tail-flick test, formalin test or endotoxin-induced hyperalgesia as well as in models of neuropathic pain like nerve ligation. Glutamate, gamma-aminobutyric acid, and particularly, opioid neurotransmission have been demonstrated to be involved in melatonin's analgesia. Results using melatonin receptor antagonists support the participation of melatonin receptors in melatonin's analgesia. However, discrepancies between the affinity of the receptors and the very high doses of melatonin needed to cause effects in vivo raise doubts about the uniqueness of that physiopathological interpretation. Indeed, melatonin could play a role in pain through several alternative mechanisms including free radicals scavenging or nitric oxide synthase inhibition. The use of melatonin analogs like the MT1/MT2 agonist ramelteon, which lacks free radical scavenging activity, could be useful to unravel the mechanism of action of melatonin in analgesia. Melatonin has a promising role as an analgesic drug that could be used for alleviating pain associated with cancer, headache or surgical procedures. Fil: Srinivasan, Venkataramanujam. Shri Sathya Sai Medical College and Research Institute; India Fil: Pandi Perumal, Seithikurippu R.. Somnogen; Estados Unidos Fil: Spence, David Warren. Canadian Sleep Society; Canadá Fil: Moscovitch, Adam. Canadian Sleep Society; Canadá Fil: Trakht, Ilya. Columbia University College of Physicians and Surgeons; Estados Unidos Fil: Brown, Gregory M.. University of Toronto; Canadá Fil: Cardinali, Daniel Pedro. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Facultad de Ciencias Médicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina |
description |
Melatonin is a remarkable molecule with diverse physiological functions. Some of its effects are mediated by receptors while other, like cytoprotection, seem to depend on direct and indirect scavenging of free radicals not involving receptors. Among melatonin's many effects, its antinociceptive actions have attracted attention. When given orally, intraperitoneally, locally, intrathecally or through intracerebroventricular routes, melatonin exerts antinociceptive and antiallodynic actions in a variety of animal models. These effects have been demonstrated in animal models of acute pain like the tail-flick test, formalin test or endotoxin-induced hyperalgesia as well as in models of neuropathic pain like nerve ligation. Glutamate, gamma-aminobutyric acid, and particularly, opioid neurotransmission have been demonstrated to be involved in melatonin's analgesia. Results using melatonin receptor antagonists support the participation of melatonin receptors in melatonin's analgesia. However, discrepancies between the affinity of the receptors and the very high doses of melatonin needed to cause effects in vivo raise doubts about the uniqueness of that physiopathological interpretation. Indeed, melatonin could play a role in pain through several alternative mechanisms including free radicals scavenging or nitric oxide synthase inhibition. The use of melatonin analogs like the MT1/MT2 agonist ramelteon, which lacks free radical scavenging activity, could be useful to unravel the mechanism of action of melatonin in analgesia. Melatonin has a promising role as an analgesic drug that could be used for alleviating pain associated with cancer, headache or surgical procedures. |
publishDate |
2010 |
dc.date.none.fl_str_mv |
2010-03 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/98829 Srinivasan, Venkataramanujam; Pandi Perumal, Seithikurippu R.; Spence, David Warren; Moscovitch, Adam; Trakht, Ilya; et al.; Potential use of melatonergic drugs in analgesia: Mechanisms of action; Pergamon-Elsevier Science Ltd; Brain Research Bulletin; 81; 4-5; 3-2010; 362-371 0361-9230 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/98829 |
identifier_str_mv |
Srinivasan, Venkataramanujam; Pandi Perumal, Seithikurippu R.; Spence, David Warren; Moscovitch, Adam; Trakht, Ilya; et al.; Potential use of melatonergic drugs in analgesia: Mechanisms of action; Pergamon-Elsevier Science Ltd; Brain Research Bulletin; 81; 4-5; 3-2010; 362-371 0361-9230 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0361923009003670 info:eu-repo/semantics/altIdentifier/doi/10.1016/j.brainresbull.2009.12.001 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Pergamon-Elsevier Science Ltd |
publisher.none.fl_str_mv |
Pergamon-Elsevier Science Ltd |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1846083006603722752 |
score |
13.22299 |